相关实验视频

Updated: Jun 15, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

在心脏性休克中使用皮革机械循环支持设备:根据最近的证据进行叙述性审查

Vincenzo Paragliola^1,2, Marco Gamardella³, Luca Franchin²

¹Division of Cardiology, School of Medicine and Surgery, Università degli Studi di Tor Vergata, 00133 Rome, Italy.

Journal of clinical medicine

|November 13, 2025

概括

心脏性休克 (CS) 的管理仍然具有挑战性. 穿皮机械循环支持 (pMCS) 设备显示生存益处有限,并发症率较高,需要仔细选择患者和进一步研究.

科学领域:

心脏病学心脏病学
关键护理医学关键护理医学
医疗器械医疗器械

背景情况:

心脏性休克 (CS) 是一种高死亡率的危及生命的疾病,通常是由急性心肌梗塞 (AMI) 引起的.
心血管血管血管和干预学会 (SCAI) 的分类有助于对CS的风险分层和临床决策.
穿皮机械循环支持 (pMCS) 设备旨在改善CS中的血液动力学,但已显示出混合的结果.

研究的目的:

审查当前的证据和临床考虑在心脏性休克 (CS) 中使用穿皮机械循环支持 (pMCS) 设备.
评估各种pMCS设备的有效性和安全性,包括大动脉内气球 (IABP),Impella和静脉动脉外体膜氧化器 (VA-ECMO).

主要方法:

对CS中pMCS的随机试验,元分析和里程碑研究 (例如ECLS-SHOCK,DanGer) 的审查.
对组合的pMCS策略 (例如,ECPELLA,ECMO + IABP) 的观察数据的分析.
在特定故障类型 (例如,Impella RP,Bi-Pella) 中选择设备时考虑血液动力学指导.

主要成果:

随机试验并没有始终显示Impella对IABP的生存优势,报告的并发症率更高.
具有里程碑意义的试验的相互矛盾的结果突出了患者严重程度和设备时间的影响.
结合策略和专用设备可以解决特定的血液动力学挑战,但具有相当大的并发症率和有限的可靠数据.

结论:

目前的证据表明,pMCS在CS中的好处仅限于精心挑选的患者子组.
早期诊断,及时转诊和个性化治疗策略对于管理CS至关重要.
进一步强大的随机对照试验对于确定pmcs在AMI相关CS中的最佳作用和时间至关重要.

关键词:

伊姆佩拉 (Impella) 是一种.在VA-ECLS中使用VA-ECLS.这就是VA-ECMO.心脏发生的冲击是心脏性冲击.机械循环支持机械循环支持微轴流量是一个微轴流量.心肌梗塞的心脏病发作

更多相关视频

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

The Intra-Aortic Balloon Pump

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

相关概念视频

Cardiopulmonary Resuscitation IV: Pharmacological Management

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Blood Pressure Imbalances and Circulatory Shock

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...